Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Gastro-intestinal Stromal Tumors (GIST)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT02606097
What this trial is testing

Regorafenib in GIST With Secondary C-KIT Exon 17 Mutation

Who this might be right for
Gastrointestinal Stromal Tumour (GIST)
Chang Gung Memorial Hospital 19
Not applicableUnknownNCT02776878
What this trial is testing

A Clinical Trial Evaluating the Efficacy and Safety of Dasatinib in Refractory Metastatic GIST

Who this might be right for
Gastrointestinal Stromal Tumor
Peking University Cancer Hospital & Institute 57
Early research (Phase 1)Study completedNCT03291288
What this trial is testing

Effect of Pexidartinib on the Way the Body Processes CYP3A4 and CYP2C9 Substrates (Pharmacokinetics)

Who this might be right for
Drug Interaction Potential
Daiichi Sankyo 32
Testing effectiveness (Phase 2)UnknownNCT02365441
What this trial is testing

A Randomised Trial of Imatinib Alternating With Regorafenib Compared to Imatinib Alone for the First Line Treatment of Advanced Gastrointestinal Stromal Tumour (GIST)

Who this might be right for
Gastrointestinal Stromal Tumour
Australasian Gastro-Intestinal Trials Group 78
Very early researchStudy completedNCT04006769
What this trial is testing

Entacapone Combination With Imatinib for Treatment of GIST

Who this might be right for
Gastrointestinal Stromal Tumor, Malignant
Xiangya Hospital of Central South University 5
Not applicableUnknownNCT03082079
What this trial is testing

Long Outcome of Endoscopic Submucosal Dissection for Small Gastrointestinal Stromal Tumors (<2cm)

Who this might be right for
GIST
Nanfang Hospital, Southern Medical University 90
Not applicableLooking for participantsNCT07697248
What this trial is testing

LRG GIST Patient Registry

Who this might be right for
GISTGIST - Gastrointestinal Stromal TumorGastrointestinal Stromal Tumor (GIST)
The Life Raft Group 5,000
Testing effectiveness (Phase 2)Ended earlyNCT00091078
What this trial is testing

Oblimersen and Imatinib Mesylate in Treating Patients With Advanced Gastrointestinal Stromal Tumors That Cannot Be Removed By Surgery

Who this might be right for
Gastrointestinal Stromal Tumor
National Cancer Institute (NCI) 96
Not applicableNo Longer AvailableNCT04714086
What this trial is testing

Expanded Access Program for Avapritinib

Who this might be right for
Solid Tumors
Blueprint Medicines Corporation
Not applicableStudy completedNCT03123432
What this trial is testing

Immunomodulating Nutrients in Perioperative Patients With Gastric Cancer

Who this might be right for
Gastric Cancer
Kaohsiung Medical University Chung-Ho Memorial Hospital 34
Large-scale testing (Phase 3)Study completedNCT01271712
What this trial is testing

Study of Regorafenib as a 3rd-line or Beyond Treatment for Gastrointestinal Stromal Tumors (GIST)

Who this might be right for
Gastrointestinal Stromal Tumors
Bayer 199
Testing effectiveness (Phase 2)Ended earlyNCT03165721
What this trial is testing

A Phase II Trial of the DNA Methyl Transferase Inhibitor, Guadecitabine (SGI-110), in Children and Adults With Wild Type GIST,Pheochromocytoma and Paraganglioma Associated With Succinate Dehydrogenase Deficiency and HLRCC-associated Kidney Cancer

Who this might be right for
ParagangliomaGastrointestinal Stromal TumorsCarcinoma, Renal Cell+2 more
National Cancer Institute (NCI) 9
Testing effectiveness (Phase 2)Study completedNCT04254939
What this trial is testing

CS3007 in Subjects With Gastrointestinal Stromal Tumor

Who this might be right for
Gastrointestinal Stromal Tumors
CStone Pharmaceuticals 65
Early research (Phase 1)Study completedNCT02686944
What this trial is testing

Evaluate the Safety of Intuvax Administered Intra-tumorally in Patients With Gastrointestinal Stromal Tumors

Who this might be right for
Gastrointestinal Stromal Tumor
Mendus 6
Testing effectiveness (Phase 2)Study completedNCT02638766
What this trial is testing

Single Agent Regorafenib in First-line for Metastatic/Unresectable KIT/PDGFR Wild Type GIST

Who this might be right for
Gastrointestinal Stromal Tumors
Grupo Espanol de Investigacion en Sarcomas 15
Not applicableLooking for participantsNCT04557969
What this trial is testing

Surgery in Gastrointestinal Stromal Tumors (GISTs) for Treatment, Tumor Modeling, and Genomic Analysis

Who this might be right for
Gastric CancerGastric NeoplasmGastrointestinal Stromal Sarcoma+2 more
National Cancer Institute (NCI) 400
Testing effectiveness (Phase 2)Ended earlyNCT01089595
What this trial is testing

Trial of Tasigna (Nilotinib) 400 mg Twice Daily Alone or With Gleevec (Imatinib Mesylate) 400 mg Daily for Patients With Advanced Gastrointestinal Stromal Tumor (GIST)

Who this might be right for
GISTMetastatic Disease
Fox Chase Cancer Center 5
Testing effectiveness (Phase 2)UnknownNCT04138381
What this trial is testing

Selinexor as Single Agent and With Imatinib in Metastatic and/or Unresectable Gastrointestinal Stromal Tumors (SeliGIST)

Who this might be right for
Maximum Tolerated DoseGISTMetastatic Adult Soft Tissue Sarcoma+2 more
Grupo Espanol de Investigacion en Sarcomas 30
Not applicableNot Yet RecruitingNCT07109024
What this trial is testing

Resistance Profiling Using Functional Imaging and Next Generation Sequencing in Refractory Gastrointestinal Stomal Tumors (GIST)

Who this might be right for
Gastrointestinal Stromal Tumor (GIST)
Universität Duisburg-Essen 40
Early research (Phase 1)Study completedNCT00397384
What this trial is testing

Erlotinib Hydrochloride and Cetuximab in Treating Patients With Advanced Gastrointestinal Cancer, Head and Neck Cancer, Non-Small Cell Lung Cancer, or Colorectal Cancer

Who this might be right for
Adenocarcinoma of the ColonAdenocarcinoma of the RectumAdvanced Adult Primary Liver Cancer+64 more
National Cancer Institute (NCI) 43
Next Page